Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… (Q88646657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

editorial

0 references

title

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Satheesh Thungappa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Jose Ferri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Christian Caglevic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Francesco Passiglia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Luis Raez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

27 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

e000162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue

26 March 2020

cites work

1 reference

12 December 2020

Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review

1 reference

12 December 2020

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

1 reference

12 December 2020

EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis.

1 reference

12 December 2020

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

1 reference

12 December 2020

10.1136/ESMOOPEN-2017-000162

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

PubMed publication ID

28761734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28761734%20AND%20SRC:MED&resulttype=core&format=json